|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02565 PEGBIO CO-B
Nominal 
46.320 +2.420 (+5.513%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (183,442) | (233,283) |
| Net Cash from / (used in) Investing Activities | -- | 114,353 | 101,622 |
| Net Cash from / (used in) Financing Activities | -- | 20,334 | 148,511 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (48,755) | 16,850 |
| Cash & Cash Equivalents at beginning of period | -- | 77,147 | 60,296 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 1 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 28,392 | 77,147 |
| Remarks: | Real time quote last updated: 08/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -93,618 |
| %Change | -39.744% |
| EPS / (LPS) | RMB -0.250 |
| NBV Per Share (¥) | RMB 0.661 |